Abstract PS2-09-09: Early on-treatment PD-L1 expression and stromal tumor infiltrating lymphocytes (sTILs) refine the prediction of EFS in the NeoTRIP trial
Matteo Dugo, G. Viale, H. Chiun-Sheng, D. Egle et autres
0 citationsClinical Cancer Research